Back to Search Start Over

A hub-and-spoke design for ultra-cold COVID-19 vaccine distribution

Authors :
Mark D. Rodgers
Xinglu Xu
Weihong Grace Guo
Source :
Vaccine
Publication Year :
2021
Publisher :
Elsevier BV, 2021.

Abstract

An orderly and effective vaccination campaign is essential in combating the global COVID-19 pandemic. As one of the pioneers, the U.S. Center for Disease Control proposes a phased plan to promote the vaccination process. This plan starts with vaccinating the high-priority population in Phase I, then turns to the remainder of the public in Phase II, and ends with a scale-back network in Phase III. The phased plan not only provides a sense of hope to impacted communities that this global pandemic can be defeated, but can serve as a template for other countries. To enhance this plan, this paper develops a generalizable framework for designing a hub-and-spoke vaccination dispensing network to achieve the goals in the Phase 2, which aims to expand the vaccination coverage for the general public. We introduce a new coverage index to measure the priority of different potential dispensing sites based on geo-data and develop an optimization model for network design. The hub-and-spoke network enhances the accessibility of the vaccines to various communities and helps to overcome the challenges related to ultra-cold storage facility shortage. A case study of Middlesex County in New Jersey is presented to demonstrate the application of the framework and provide insights for the Phase 2. Results from the baseline scenario show that increasing the driving time limit from 10 minutes to 25 minutes can improve the total coverage index from 40.8 to 55.9. Additionally, we explore how the changes of parameters impact the network design and discuss potential solutions for some special cases. When we allow 4 outreach nodes per hub, all potential 45 outreach points can be covered in the vaccination network within a 20-minute drive, and the total coverage index reaches its maximum value of 58.3.

Details

ISSN :
0264410X
Volume :
39
Database :
OpenAIRE
Journal :
Vaccine
Accession number :
edsair.doi.dedup.....cdd27a76dfa119ebd9902cdcc84186ff